Oka Suguru, Hara Tomohiko, Ito Shinji, Hayashida Michikata, Sakaguchi Kazushige, Urakami Shinji
Department of Urology, Toranomon Hospital, Tokyo, Japan.
Department of Pathology, Toranomon Hospital, Tokyo, Japan.
Eur Urol Open Sci. 2023 Dec 29;59:78-89. doi: 10.1016/j.euros.2023.12.004. eCollection 2024 Jan.
The epidemiology of metastases from rare genitourinary cancer and metastases to genitourinary organs from other primary neoplasms remains poorly understood.
To investigate the epidemiology of rare genitourinary metastases from rare genitourinary organ-type cancer and to genitourinary organs using data from a large national autopsy registry in Japan.
A secondary analysis of the data reported in the Annual of the Pathological Autopsy Cases in Japan and the Japanese Mortality Database from 1993 to 2020 was performed.
Via a retrospective epidemiologic analysis, we evaluated the frequency (probability of occurrence [number per person]) and proportion (percentage) of metastases from upper urinary tract, adrenal, testicular, urethral, and penile cancers. Moreover, the sites of primary tumors metastasizing to genitourinary organs were examined.
In Japan, the mortality rate of upper urinary tract cancer is increasing rapidly. In the integrated database with 365 099 autopsies and 835 959 metastatic organs, the major metastatic sites (range of frequency ratios) of rare genitourinary organ-type cancers were the lungs (0.38-0.47), liver (0.21-0.56), bone (0.16-0.33), adrenal gland (0.10-0.20), peritoneum (0.0-0.16), and kidneys (0.07-0.22). The major primary sites (range of proportions) of genitourinary organ metastases were the respiratory tract (5.6-34.0%), stomach (4.7-27.0%), hematologic site (0.9-24.9%), lymphoid (2.4-22.2%), bladder (0.8-20.0%), prostate (0.7-14.1%), rectal (2.0-11.7%), and pancreas (2.6-11.0%). The cancers with a high likelihood of genitourinary metastasis were respiratory and stomach cancers. However, the study lacked individual-level information, and there might be a concomitant selection bias in this autopsy study.
This large-scale autopsy database analysis identified the epidemiology of metastasis from rare genitourinary organ-type cancer and the origins of metastasis to genitourinary organs.
This study provides valuable metastatic epidemiologic data and clinical information that are fundamental to the mechanisms of genitourinary metastasis.
罕见泌尿生殖系统癌症的转移流行病学以及其他原发性肿瘤转移至泌尿生殖器官的情况仍了解甚少。
利用日本一个大型全国尸检登记处的数据,调查罕见泌尿生殖器官类型癌症的罕见泌尿生殖系统转移以及转移至泌尿生殖器官的情况。
设计、背景与参与者:对1993年至2020年《日本病理尸检病例年报》和日本死亡率数据库中报告的数据进行二次分析。
通过回顾性流行病学分析,我们评估了上尿路、肾上腺、睾丸、尿道和阴茎癌转移的频率(发生概率[每人例数])和比例(百分比)。此外,还检查了转移至泌尿生殖器官的原发性肿瘤部位。
在日本,上尿路癌的死亡率正在迅速上升。在包含365099例尸检和835959个转移器官的综合数据库中,罕见泌尿生殖器官类型癌症的主要转移部位(频率比范围)为肺(0.38 - 0.47)、肝(0.21 - 0.56)、骨(0.16 - 0.33)、肾上腺(0.10 - 0.20)、腹膜(0.0 - 0.16)和肾(0.07 - 0.22)。泌尿生殖器官转移的主要原发部位(比例范围)为呼吸道(5.6 - 34.0%)、胃(4.7 - 27.0%)、血液系统部位(0.9 - 24.9%)、淋巴组织(2.4 - 22.2%)、膀胱(0.8 - 20.0%)、前列腺(0.7 - 14.1%)、直肠(2.0 - 11.7%)和胰腺(2.6 - 11.0%)。发生泌尿生殖系统转移可能性较高的癌症是呼吸道癌和胃癌。然而,该研究缺乏个体层面的信息,并且在这项尸检研究中可能存在伴随的选择偏倚。
这项大规模尸检数据库分析确定了罕见泌尿生殖器官类型癌症转移的流行病学以及转移至泌尿生殖器官的起源。
本研究提供了有价值的转移流行病学数据和临床信息,这些对于泌尿生殖系统转移机制至关重要。